Study sheds light on night work−cancer link

A new study has offered insights into the association between night shift work and increased cancer risk, as well as pointing towards a potential solution.

For several years, scientists have thought that disruption to the body’s natural circadian rhythm is accountable for the increased cancer risk, but the mechanisms behind this have not yet been pinpointed.

Now, US researchers have published findings that suggest night shift work reduces the body’s ability to repair damaged DNA, thereby increasing the risk of mutations developing.

As reported in Occupational & Environmental Medicine, the study tested the urine of 50 night shift workers for the chemical 8-hydroxydeoxyguanosine (8-OH-dG) – a substance that reacts with DNA to cause mutation, unless the DNA is repaired. The participants were then tested again when they were working days.

“Your repair machinery cuts out that damage and it’s actually excreted in urine so we can measure the repaired damage in urine,” explains lead author Parveen Bhatti (Fred Hutchinson Cancer Research Center, Seattle). People with higher versus lower levels of 8-OH-dG in the urine may be benefiting more from their body’s DNA repair mechanisms.

The researchers found that when people work nights, 80% less 8-OH-dG is excreted in the urine, suggesting that the crucial DNA repair is not being carried out as it should be.

“The damage was done but it wasn’t repaired,” said Bhatti. “It’s sitting in their cells.”

The study also confirmed that the night workers’ reduced DNA repair was linked to lower levels of circulating melatonin and that lower melatonin levels were linked to decreased 8-OH-dG levels.

“What seems to be happening, and this is supported by a lot of animal and cellular evidence, is melatonin normally drives repair of damage,” says Bhatti. “So, with low levels of melatonin, their repair machinery isn’t functioning at optimal levels.”

Bhatti now wants to conduct another study to investigate whether melatonin supplementation would allow night workers to carry out DNA repair as they sleep in the day.

“If such effects are confirmed, melatonin supplementation should be explored as an intervention to reduce the occurrence of potentially carcinogenic DNA damage among shift workers,” he concludes.

Sources

Sally Robertson

Written by

Sally Robertson

Sally has a Bachelor's Degree in Biomedical Sciences (B.Sc.). She is a specialist in reviewing and summarising the latest findings across all areas of medicine covered in major, high-impact, world-leading international medical journals, international press conferences and bulletins from governmental agencies and regulatory bodies. At News-Medical, Sally generates daily news features, life science articles and interview coverage.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2018, August 23). Study sheds light on night work−cancer link. News-Medical. Retrieved on July 11, 2020 from https://www.news-medical.net/news/20170627/Study-sheds-light-on-night-worke28892cancer-link.aspx.

  • MLA

    Robertson, Sally. "Study sheds light on night work−cancer link". News-Medical. 11 July 2020. <https://www.news-medical.net/news/20170627/Study-sheds-light-on-night-worke28892cancer-link.aspx>.

  • Chicago

    Robertson, Sally. "Study sheds light on night work−cancer link". News-Medical. https://www.news-medical.net/news/20170627/Study-sheds-light-on-night-worke28892cancer-link.aspx. (accessed July 11, 2020).

  • Harvard

    Robertson, Sally. 2018. Study sheds light on night work−cancer link. News-Medical, viewed 11 July 2020, https://www.news-medical.net/news/20170627/Study-sheds-light-on-night-worke28892cancer-link.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
World's first clinical trial of immune-boosting strategy to protect cancer patients from COVID-19